The 2021 United Nations Climate Change Conference (COP26), held at the SEC Centre in Glasgow.
Abstract: A new global agreement – the Glasgow Climate Pact – was reached at the COP26 summit. It aims to reduce the…
India
Sun Pharma Plans to Launch Merck’s Covid pill Molnupiravir Under the Brand Name Molxvir® in India Soon.
KEYPOINTS Sun Pharmaceutical Industries is getting set to bring out its version of molnupiravir, the anti-viral drug from Merck Sharpe Dohme and…
The United Kingdom becomes the First Country to Approve Molnupiravir Merck`s Oral Antiviral Drug
KEYPOINTS: The UK became the first country to approve Covid-19 antiviral pill, jointly developed by US-based Merck & Co Inc and Ridgeback…
WHO grants Most-awaited Emergency Use Listing to Bharat Biotech’s Covaxin.
SUMMARY: WHO grant of EUL will ease international travel for those vaccinated with the Bharat Biotech`s Covaxin and the WHO clearance is a…
Agastya Agro Ltd, (Hyderabad) India and Primary BioAg Innovations, USA joined hands, entered an agreement for collaboration.
SUMMARY: Agastya Agro is in agreement with US-based Primary BioAg Innovations. Under the partnership, Primary BioAg Innovations will commercialize its product portfolio…
Grim Situation for India Dengue Cases Spike up.
Dengue is an acute viral infection with potential fatal complications. Dengue fever was first referred as “water poison” associated with flying insects…
Australia has added Bharat Biotech’s Covaxin to the approved list of COVID vaccines.
KEYPOINTS: Australia’s medicines and medical devices regulator on Monday formally recognised India’s Covaxin, a vaccine against the coronavirus as the country’s border…
Novavax partner of Serum Institute of India Receives Emergency Use Authorization for COVID-19 Vaccine (COVOVAX) in Indonesia.
KEYPOINTS: Novavax Inc and partner Serum Institute of India said on Monday they received emergency use authorization for their Covid-19 vaccine in…
Indian Government Invited Stakeholders Opinion On New Draft Policy by 6 Nov,2021
The Department of Pharmaceuticals (DoP) has come out with a draft policy to catalyse research and development (R&D) and innovation in…
The New Policy Draft By Indian Government to Empower Pharma – MedTech Sector
Introduction The Medical Device industry is highly capital intensive with a long gestation period and requires development and induction of new technologies.…